2019年5月6日，由深圳华大生命科学研究院联合东南大学、华东理工大学、清华大学、中国食品药品检定研究院共同承担的国家重点研发计划“精准医学研究”重点专项《新一代基因组测序技术、临床用测序设备及配套试剂的研发》的项目中期现场检查会在华大总部召开。 国家卫生健康委医药卫...
Shenzhen, May 14, 2019 - BGI Genomics and Pryzm Health, digital health start-up, signed a Memorandum of Understanding (MoU) for collaboration to advance precision public health in Australia.With their complementary expertise and technology, BGI Genomics and Pryzm Health will develop foundational ca...
BGI Bioverse adheres to the tenet of “Harmony among nature, earth and mankind, everything coexists”, relying on the advantages of BGI's multi-omics big data platform, it innovates technologies such as whole-genome design breeding, gene editing, and synthetic biology to quickly and accurately cul...
New York City, September 23rd, 2019 – The strategic partnership between SpaceTime Ventures and BGI Group was announced today at the World Economic Forum's Sustainable Development Impact Summit in New York City to unleash a new Inclusive Bio-Economy in the Tropics. To-date, b...
International consortium of researchers generates gene sequences from more than 1100 plantspecies Image caption: Green alga Lacunastrum gracillimum, female cones of gymnosperm, Gnetum gnemon, and cherry tree flower, Prunus domestica. Photo credits: Michael Melkonian and WalterS. Judd. ...
BGI Group headquartered in Shenzhen, China, is the world’s largest genome research organization innovating at the forefront of genomic technologies. VIB, headquartered in Ghent, Belgium, is a leading life science institute excelling in ground breaking research and translating science into innovat...